AR025923A1 - Nueva combinacion de loteprednol y antihistaminicos - Google Patents

Nueva combinacion de loteprednol y antihistaminicos

Info

Publication number
AR025923A1
AR025923A1 ARP000105166A ARP000105166A AR025923A1 AR 025923 A1 AR025923 A1 AR 025923A1 AR P000105166 A ARP000105166 A AR P000105166A AR P000105166 A ARP000105166 A AR P000105166A AR 025923 A1 AR025923 A1 AR 025923A1
Authority
AR
Argentina
Prior art keywords
loteprednol
new combination
antihistaminics
rhinoconjunctivitis
levocabastine
Prior art date
Application number
ARP000105166A
Other languages
English (en)
Original Assignee
Meda Pharma Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Pharma Gmbh & Co Kg filed Critical Meda Pharma Gmbh & Co Kg
Publication of AR025923A1 publication Critical patent/AR025923A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe una nueva combinacion de un esteroide suave, en especial el loteprednol, y por lo menos un antihistamínico, como por ejemplo la azelastina y/ola levocabastina, para la aplicacion simultánea, secuencial o separada en el tratamiento local de alergias y de enfermedades de las vías respiratorias, porejemplo de la rinitis alérgica (rinoconjuntivitis).
ARP000105166A 1999-09-30 2000-09-29 Nueva combinacion de loteprednol y antihistaminicos AR025923A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19947234A DE19947234A1 (de) 1999-09-30 1999-09-30 Neue Kombination von Loteprednol und Antihistaminika

Publications (1)

Publication Number Publication Date
AR025923A1 true AR025923A1 (es) 2002-12-18

Family

ID=7924100

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105166A AR025923A1 (es) 1999-09-30 2000-09-29 Nueva combinacion de loteprednol y antihistaminicos

Country Status (19)

Country Link
US (1) US7022687B1 (es)
EP (1) EP1216046B1 (es)
JP (2) JP5524438B2 (es)
AR (1) AR025923A1 (es)
AT (1) ATE241988T1 (es)
AU (1) AU7907300A (es)
BR (1) BR0014312B1 (es)
CA (1) CA2387398C (es)
CZ (1) CZ295090B6 (es)
DE (2) DE19947234A1 (es)
DK (1) DK1216046T3 (es)
EE (1) EE04997B1 (es)
ES (1) ES2199868T3 (es)
HU (1) HU229606B1 (es)
MX (1) MXPA02003174A (es)
PL (1) PL196843B1 (es)
PT (1) PT1216046E (es)
TW (1) TWI224968B (es)
WO (1) WO2001022955A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE317268T1 (de) * 2001-12-05 2006-02-15 Alcon Inc Verwendung eines h1-antagonisten und von rimexolon als sicheres steroid zur behandlung von rhinitis
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
EP1545548B1 (en) * 2002-08-30 2010-06-30 Nycomed GmbH The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
CA2504200A1 (en) * 2002-11-12 2004-05-27 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis
JP4755495B2 (ja) 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
US20060263350A1 (en) * 2003-09-26 2006-11-23 Fairfield Clinical Trials Llc Combination antihistamine medication
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
ATE441419T1 (de) * 2004-03-25 2009-09-15 Bausch & Lomb Verwendung von loteprednoletabonat zur behanldung von trockenen augen
PL2486942T3 (pl) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
BR112013017183A2 (pt) * 2011-01-04 2017-07-25 Bausch & Lomb composições de bepostatina
WO2013177594A2 (en) * 2012-05-25 2013-11-28 Xlear, Inc. Xylitol-based anti-mucosal compositions and related methods and compositions
US10898493B2 (en) 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US11938139B2 (en) 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
EP0709099A3 (en) * 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
WO1997001337A1 (en) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
JP4453987B2 (ja) * 1997-01-16 2010-04-21 千寿製薬株式会社 点鼻用水性懸濁液

Also Published As

Publication number Publication date
US7022687B1 (en) 2006-04-04
EP1216046A2 (de) 2002-06-26
EE04997B1 (et) 2008-04-15
DE19947234A1 (de) 2001-04-05
CA2387398C (en) 2009-05-12
JP2003510275A (ja) 2003-03-18
DE50002478D1 (de) 2003-07-10
CZ20021014A3 (cs) 2002-06-12
AU7907300A (en) 2001-04-30
HUP0202862A2 (hu) 2003-01-28
EE200200146A (et) 2003-04-15
WO2001022955A2 (de) 2001-04-05
PL353486A1 (en) 2003-11-17
JP2012001558A (ja) 2012-01-05
CZ295090B6 (cs) 2005-05-18
CA2387398A1 (en) 2002-03-28
BR0014312B1 (pt) 2012-09-04
WO2001022955A3 (de) 2001-05-17
TWI224968B (en) 2004-12-11
EP1216046B1 (de) 2003-06-04
JP5524438B2 (ja) 2014-06-18
ATE241988T1 (de) 2003-06-15
HUP0202862A3 (en) 2003-10-28
ES2199868T3 (es) 2004-03-01
MXPA02003174A (es) 2003-08-20
BR0014312A (pt) 2002-05-21
PL196843B1 (pl) 2008-02-29
PT1216046E (pt) 2003-10-31
DK1216046T3 (da) 2003-09-29
HU229606B1 (en) 2014-02-28

Similar Documents

Publication Publication Date Title
AR025923A1 (es) Nueva combinacion de loteprednol y antihistaminicos
PE34998A1 (es) Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DE60325916D1 (de) Entscheidungseinheit für die Verwaltung von Diensten und Vorrichtungen
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
DE60131881D1 (de) Topische zusammensetzung enthaltend mindestens ein vitamin d oder vitamin d analogon und mindestens ein corticosteroid
BR0107691A (pt) Sapogeninas substituìdas e seu uso
AU2003246102A1 (en) Method of examining allergic disease and drug for treating the same
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
DE69932510D1 (de) Vaskularisierungsinhibitoren
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
AR028448A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
HN2002000366A (es) Anticuerpo que inhibe la actividad del factor de las celulas precursoras y su uso para el tratamiento del asma
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
HRP20031057B1 (hr) Tableta koja sadrži cetirizin i pseudoefedrin
NO20024735D0 (no) Anvendelse av fulvestrant for behandling av resistent brystcancer
AR041595A1 (es) Tratamiento terapeutico
CO5261512A1 (es) Metodo y composiciones para el tratamiento de las enfermedades pulmonares
AR020740A1 (es) Composicion y metodo para tratar enfermedades alergicas
NO20053247L (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.
DE60327946D1 (de) Angiogen-wirkende trisulfat steroide und deren verwendung
AR025924A1 (es) Combinacion de loteprednol y agonistas de beta2-adrenoceptores

Legal Events

Date Code Title Description
FC Refusal